top of page

The FDA's Renewed Focus on Cybersecurity

Sep 13

3 min read

0

0

0

The FDA's increased focus on cybersecurity in medical device evaluation is a positive step for patient safety in our increasingly connected healthcare world. However, navigating these new regulations presents challenges for manufacturers. This article explores these challenges and the potential benefits of partnering with Rx Device Consulting to ensure a smooth and secure path to market.


The Evolving Landscape

In recent years, the FDA has issued guidance documents outlining cybersecurity best practices for medical devices, such as "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions". These documents emphasize risk assessments, exploitability analysis, and post-market patching support. While these are crucial steps, implementing them can be complex.


Challenges on the Road to Compliance

One key challenge lies in addressing legacy devices. The FDA's current focus primarily impacts new devices, leaving a large number of existing devices in a cybersecurity grey area. This creates uncertainty for manufacturers on how to best manage these devices and their potential vulnerabilities.


Another hurdle is the ever-evolving threat landscape. Cybersecurity risks are constantly changing, and manufacturers need to be adaptable to stay ahead of potential attacks. The FDA acknowledges this in its guidance documents, recommending manufacturers plan for the entire device lifecycle, including ongoing security updates. However, developing and implementing these plans requires ongoing vigilance and expertise. We have seen companies spend several tens of thousands for a consulting firm to pen test their platform, only to have FDA say that due to new threats, the pen testing needs to be redone and also needs to be performed on an ongoing basis. We have partnerships with various companies that offer “Pen Testing as a Service” and can help set up a robust, ongoing, and cost-effective pen testing program and help you communicate this approach to FDA in your marketing applications and audits.


FDA’s approach to cybersecurity is also changing and impacting the traditional norms of medical device development. For instance, FDA no longer accepts a risk management framework based on ISO 14971 (one of the most foundational medical device risk management standards) to manage cybersecurity risks and there are no generally accepted industry standards specific to medical device cybersecurity risk management. We have years of experience dealing with this and can help develop a robust framework for your new and legacy devices.


The Power of Partnership

Rx Device Consulting has extensive expertise in FDA cybersecurity requirements and can be a valuable asset in navigating these challenges. We can assist with:

  • Gap Analysis: Identifying areas where current practices may not align with the FDA's expectations.

  • Threat Modeling: Support cybersecurity best practices that FDA recommends related to threat modeling, SBOM and other third-party software documentation requirements, architecture views, and security testing.

  • Risk Assessment: Developing a comprehensive plan to identify, assess, and mitigate cybersecurity risks for both new and existing devices. 

  • Validation and Pen Testing: Defining and managing security testing, including pen testing on an ongoing basis to address the evolving threat landscape and comply with FDA requirements.

  • Documentation and Training: Creating clear and compliant documentation, and training staff on cybersecurity best practices.


By partnering with us, manufacturers can gain the necessary expertise to achieve and maintain compliance, ensuring the safety and efficacy of their devices in a connected healthcare environment.

Conclusion

The FDA's focus on cybersecurity is a necessary step towards protecting patients in the digital age. However, manufacturers face challenges in implementing these new requirements. Rx Device Consulting can be a valuable partner in ensuring a smooth and secure path to market, ultimately prioritizing patient safety and innovation.


About Rx Device Consulting

Rx Device Consulting is a medical device product development and regulatory consulting team, with a core focus on digital health, wearable technology, software (SaMD, SiMD, etc.), imaging, and additive manufacturing technologies. Learn more by visiting our website or email us at info@rxdeviceconsulting.com for more information.




Comments

Share Your ThoughtsBe the first to write a comment.
bottom of page